Melanoma: open trials in Belgium

19 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT07492680
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Trial Treatment · Phase 2 · Bristol-Myers Squibb
UZ Brussel, Brussels · Cliniques universitaires Saint-Luc, Brussels · UZ Gent, Ghent
Registry updated 2026-11-04
NCT07224425
A Study of BI 3810944 in Patients With Advanced Cancer
Trial Treatment · Phase 1 · Boehringer Ingelheim
UZ Leuven, Leuven · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-30
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Cliniques universitaires Saint-Luc, Brussels · UZA, Edegem · Universitair Ziekenhuis Gent, Ghent · Universitair Ziekenhuis Brussel, Jette · UZ Leuven, Leuven
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Grand Hopital de Charleroi, Charleroi · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-26
NCT07883954
Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test
Research · Mitra Bio
Ghent university hospital, Ghent
Registry updated 2026-10-21
NCT07070232
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Trial Treatment · Phase 1/2 · BioNTech SE
Institut Jules Bordet, Anderlecht · Universitair Ziekenhuis Gent, Ghent · Centre Hospitalier Universitaire de Liège, Liège · Ziekenhuis Aan de Stroom ZAS vzw, Wilrijk
Registry updated 2026-10-09
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Antwerp University Hospital, Edegem · Algemeen Ziekenhuis Groeninge, Kortrijk · UZ Leuven, Leuven · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Vitaz, Sint-Niklaas · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2026-10-06
NCT05727904
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Trial Treatment · Phase 3 · Iovance Biotherapeutics, Inc.
UZ Brussel, Jette
Registry updated 2026-09-24
NCT07338968
A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
Research · Phase 3 · Aura Biosciences
Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-08-19
2025-521164-36-00
A phase 1/2a, first-in-human, open-label, dose-escalating study with a safety expansion cohort to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumour activity of TAX2 in patients with relapsed/refractory advanced/metastatic solid tumours
Trial Treatment · Phase 1/2 · Apmonia Therapeutics
Institut Jules Bordet, Anderlecht · Universitair Ziekenhuis Gent, Gent
Registry updated 2026-07-01
NCT06246149
Adjuvant Tebentafusp in High Risk Ocular Melanoma
Trial Treatment · Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC
Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-06-30
2023-510544-21-00
INtra-tumor miCro dosIng in PatIents with advanced malignant mElanoma receiving aNti-PD1 Therapy. A pilot study.
Trial Treatment · Phase 1 · UZ Leuven
UZ Leuven, Leuven
Registry updated 2026-06-18
NCT07266142
Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker
Research · Universitaire Ziekenhuizen KU Leuven
UZLeuven, Department of Dermatology, Leuven
Registry updated 2026-06-12
2024-517840-68-00
A phase 2 clinical trial on neoadjuvant pembrolizumab in patients diagnosed with high-risk melanoma without clinical evidence of metastatic dissemination.
Trial Treatment · Phase 2 · UZ Brussel
UZ Brussel, Jette
Registry updated 2026-06-05
NCT07015190
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Trial Treatment · Phase 3 · IDEAYA Biosciences
UZ Leuven, Leuven · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-05-06
NCT07448831
A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.
Trial Treatment · Phase 2 · Universitair Ziekenhuis Brussel
UZ Brussel, Jette
Registry updated 2026-03-09
NCT05549297
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Trial Treatment · Phase 3 · Immunocore Ltd
UZ Brussel, Jette · UZ Leuven, Leuven · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-02-25
NCT06112314
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Trial Treatment · Phase 3 · Immunocore Ltd
Universite Libre de Bruxelles (ULB)-Institut Jules Bordet, Anderlecht · AZ Sint-Jan Brugge-Oostende AV-Campus Sint-Jan, Bruges · Universitair Ziekenhuis Brussel, Brussels · Cliniques Universitaires Saint-Luc - Institut Roi Albert II, Brussels · UZ Leuven, Leuven
Registry updated 2026-02-25
NCT04498767
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Trial Treatment · European Organisation for Research and Treatment of Cancer - EORTC
Institut Jules Bordet, Anderlecht · Universitair Ziekenhuis Gent, Ghent · Gasthuiszusters Antwerpen - Sint-Augustinus, Wilrijk
Registry updated 2024-08-26

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error